Scott A. Reed

Director Scott A. Reed bought 5,000 shares at $3.10 across two dates for $15,500.00 at CFND, against a -66.6% 52-week downtrend.

Scott A. Reed purchased 5,000 shares in two transactions totaling $15,500.00 at $3.10 per share on 2026-06-11 and 2026-06-12, raising his stake from 47,000 to 52,000 shares. The current price of $3.27 is -66.6% from the 52-week high of $9.78, and the stock has declined -20.2% over the past 90 days. Reed's prior five purchases at CFND all showed negative 90-day returns (ranging from -23.4% to -30.5%), with a 0 of 5 well-timed rate at the 90-day mark. His cross-ticker buy track record shows 11 prior buys with average 90-day returns of -26.4% and a 0.00% win rate, indicating a consistent pattern of unfavorable entry timing across holdings. This purchase occurs against that backdrop of deteriorating price action and historically poor timing on his buys at this ticker.

Director Scott A. Reed purchased 15,000 shares (15.0K) for $47,000.00 at CFND; stock down 68.1% from 52-week high, but Reed's prior CFND buys yielded 0 of 5 well-timed at 90-day mark.

Scott A. Reed, Director of C1 Fund Inc., made 2 separate purchases totaling 15,000 shares for $47,000.00 on 2026-06-08 and 2026-06-09 at blended average price $3.13, increasing his holdings by 46.9% to 47,000 shares post-transaction. The stock is currently trading at $3.12, down 68.1% from its 52-week high of $9.78 and down 20.6% over the prior 90 days. Reed's prior trading history at CFND shows 5 earlier buys completed between 2025-12-03 and 2025-12-12, and none of those 5 purchases were well-timed at the 90-day measurement window—each resulted in negative 90-day returns ranging from -23.4% to -30.5%. This persistent pattern of ill-timed purchases at this same ticker over a six-month period, combined with the current depressed valuation, suggests Reed continues to accumulate despite a historical pattern of subsequent declines.

CFND Director Reed Scott A. purchases 5,000 shares in 2 transactions ($25,595 total) amid -49.0% decline from 52-week high

Director Reed Scott A. made 2 separate purchases totaling 5,000 shares for $25,595.00 at blended average price $5.12 on 2025-12-11 and 2025-12-12. The stock currently trades at $4.93, down -49.0% from its 52-week high of $9.67 and -25.3% over the past 30 days. His holdings increased 18.5% to 32,000 shares post-transaction. Notably, this buying activity follows a pattern: Reed has made 5 prior purchases at CFND between 2025-12-01 and 2025-12-04 alone, indicating sustained accumulation within a compressed timeframe as the stock has declined sharply. His cross-ticker track record shows 9 prior open-market buys with 0.00% win rate at 90 days (average 90d return -26.8%), a pattern that provides limited confidence in the timing of this accumulation.

Director Reed Scott A. purchased 12,500 shares of CFND for $65,225.00 on 2025-12-04, raising stake 83.3% to 27.5K shares.

Reed Scott A. executed two purchases totaling 12,500 shares at an average price of $5.22 on 2025-12-04, substantially increasing his position from 15,000 to 27,500 shares. This acquisition follows a pattern of repeated buying at CFND: the director placed buys on 2025-12-03, 2025-12-01 (twice), and has completed five prior trades at this ticker. However, the timing of his prior CFND purchases has been unfavorable—neither of his two measurable prior buys at CFND generated positive 90-day returns (outcomes were -31.1% and -23.2%), suggesting a pattern of purchasing before subsequent declines. The current price of $5.35 sits -44.7% from the 52-week high and -22.6% below 30-day levels, raising questions about valuation and forward momentum.

Director Reed Scott A. bought 6,500 shares of CFND at $5.31 on 2025-12-03, raising stake to 25,000 shares; stock down 44.5% from 52-week high.

Director Reed Scott A. purchased 6,500 shares at $5.31, increasing his holdings by 35.1% to 25,000 shares, coinciding with a cluster buy pattern involving 2 other insiders within the past 14 days. The transaction occurs amid significant price pressure: CFND is trading down 44.5% from its 52-week high of $9.67 and down 38.0% over the past 90 days. However, Scott's cross-ticker track record raises caution: his 8 prior open-market buys across all tickers averaged -4.6% returns after 30 days and -26.8% after 90 days with a 0.00% 90-day win rate. At this specific ticker, his prior buy on 2025-08-22 resulted in a -31.1% 90-day return, and he has achieved a 0% timing success rate on CFND buys historically. The concurrent activity by multiple insiders suggests potential coordinated conviction, but Scott's documented track record of poorly-timed purchases on both cross-ticker and CFND-specific bases presents a contradictory signal for investors evaluating the fundamental case.

Director Reed Scott A. bought 13,500 shares ($72,155.00) in 2 transactions at CFND on 2025-12-01; stock down 27.6% over 30d, 0 of 4 prior buys well-timed at 90d.

Reed Scott A. purchased 13,500 shares of C1 Fund Inc. in two separate open-market transactions on 2025-12-01 at prices near the 52-week low ($5.37 and $5.33), bringing his holdings from 5,000 to 18,500 shares (+270.0% increase). However, his prior trades at this ticker show a consistent pattern of poor timing: of his 4 prior measurable buys at CFND, none achieved a positive 90-day return, with the most recent buy on 2025-08-08 returning -30.2% over 90 days. The current price of $5.40 is -44.2% from the 52-week high and the stock has declined -27.6% over the past 30 days, consistent with the broader downtrend context in which this purchase occurred. A cluster buy pattern is present, with 2 other insiders also purchasing within the past 14 days.

Director Reed Scott A. purchased 60,000 shares across 4 transactions totaling $553,800 at blended avg $9.23

Reed Scott A., a Director at C1 Fund Inc., executed 4 separate purchases totaling 60,000 shares for $553,805.00 between August 8 and August 22, 2025. The transactions occurred at prices ranging from $8.23 to $10.00, establishing a blended average price of $9.23. His post-transaction holdings stand at 10,000 shares, whereas his pre-transaction position showed -50,000 shares—meaning he converted from a net short position to a net long position through these acquisitions. With the stock currently trading at $8.63 as of September 8, 2025, the recent activity reflects a significant directional shift. The company has been publicly listed for only 22 trading days, limiting the availability of historical context for this equity.